2-3 May 2002, Cologne
Light, Endocrine Systems and Cancer
Facts and Research Perspectives
This meeting on visible radiation and cancer will bring together
some of the worlds leading experts in the pertinent research
areas. As previously,* the emphasis will be on discussion of
plausible biomechanisms that might explain existing experimental
and epidemiological results. On this occasion the meeting will
concentrate on new ideas about observed associations between
light, the endocrine systems and cancer. Other specialists in
related research areas will provide essential background information
to stimulate further critical evaluation of the available data.
The following experts will contribute reports and comments:
GC Brainard, USA
TC Erren, Germany
A Lerchl, Germany
S Perkowitz, USA
C Poole, USA
CJ Portier, USA
RJ Reiter, USA
KP Sauer, Germany
K Scharffetter-Kochanek, Germany
G Vollmer, Germany
G Burg, Switzerland
P Cocco, Italy
T Krieg, Germany
W Krone, Germany
R Lucas, UK
M Mevissen, Switzerland
T Roenneberg, Germany
Institut und Poliklinik für Arbeits- und Sozialmedizin
der Universität zu Köln,
50924 Köln (Lindenthal), Germany.
Tel: +49 221-478-5819.
Fax: +49 221-478-5119.
The nexus of light and cancer
Session 2 Light
Ocular and neuronal physiology
Light, hormones and aging
Session 3 Endocrine systems
Endocrine modulation and the fragile balance of homeostasis
Endocrine dismodulation and cancer
Session 4 Skin cancers
Session 6 Novel research
Session 7 Perspectives
Where are we headed?
from the Symposium will be published
in the Neuroendocrinology Letters
in June 2002.
Low frequency electromagnetic fields (EMF), Visible Light, Melatonin
and Cancer - International symposium May 4-5, 2000; University
of Cologne, Germany. http://www.uni-koeln.de/symposium2000/.
are now able to accept a limited number of posters for exhibition
during the symposium. Posters must be related directly to
the theme of the meeting: observed associations
between light, the endocrine systems and cancer.
versions of abstracts of posters must reach the organisers*
for review by 29 March 2002.
on whether or not posters have been accepted will be notified
to authors by 4 April 2002.
of accepted and exhibited posters will be edited for publication
as part of the symposium Proceedings.
Proceedings are scheduled to appear in the June 2002 issue
of Neuroendocrinology Letters.
abstracts must be in English and print within 2.5 cm
margins on one side of one sheet of A4 paper. The abstract
must refer to the study objectives, methods, results
and conclusions. Please use regular 12-point Times
or Times New Roman font throughout. The text, including
title, and authors names and affiliations, may not
exceed 600 words. Use new lines for authors and for the
main text. Do not include tables, figures or charts in the
of posters may be submitted as e-mail attachments addressed
or on diskette to:
Dr Thomas Erren,
Institut und Poliklinik für Arbeits- und Sozialmedizin,
Klinikum der Universität zu Köln, D-50924 Cologne,